Intralipid vs Pedismof Preterm: Side-by-Side Comparison
Quick answer: Intralipid and Pedismof Preterm are both parenteral nutrition lipid emulsion used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Intralipid | Pedismof Preterm |
|---|---|---|
| Drug class | Parenteral nutrition lipid emulsion | Parenteral nutrition lipid emulsion |
| ATC code | B05BA02 | B05BA02 |
| Primary indications | Parenteral nutrition (caloric and essential fatty acid source), Local anesthetic systemic toxicity (off-label antidote) | Parenteral nutrition in preterm neonates |
| Mechanism | Soybean oil-based intravenous lipid emulsion providing calories and essential fatty acids; in toxicity, sequesters lipophilic drugs | Mixed lipid emulsion formulation tailored for preterm neonates providing energy and essential fatty acids in parenteral nutrition |
| Common dose | 1-2 g/kg/day IV (parenteral nutrition); 1.5 mL/kg bolus then infusion (LAST) | Individualized based on weight and gestational age |
| Detail page | Intralipid details → | Pedismof Preterm details → |
How to choose between Intralipid and Pedismof Preterm
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Parenteral nutrition lipid emulsion on iMedic · Intralipid full details · Pedismof Preterm full details
Frequently asked questions
Is Intralipid better than Pedismof Preterm?
Neither is universally 'better.' They are both parenteral nutrition lipid emulsion with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Intralipid to Pedismof Preterm?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Intralipid and Pedismof Preterm have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Intralipid and Pedismof Preterm available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.